SCHEMBL18204292

SCHEMBL18204292

CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5ccccc5C#N)ccc4=O)c3)nc2)CC1

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 20/20 0.78
▸ NQO2 P16083 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tepotinib SCHEMBL29379106 0.88 MET (1.00) METNQO2
Tepotinib SCHEMBL1296895 0.88 MET (1.00) METNQO2
SCHEMBL2527890 0.87 MET (0.80) METNQO2
Tepotinib SCHEMBL29550043 0.87 MET (0.98) METNQO2
Tepotinib SCHEMBL1296467 0.87 MET (0.98) METNQO2
Tepotinib SCHEMBL30259391 0.87 MET (0.98) METNQO2
Tepotinib SCHEMBL1295616 0.87 MET (0.98) METNQO2
SCHEMBL2530219 0.84 MET (0.84) METNQO2
SCHEMBL3088622 0.84 MET (0.80) METNQO2
SCHEMBL2457792 0.84 MET (0.80) METNQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160324855-A1 COMBINATION OF A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH GEFITINIB MERCK PATENTE GMBH (DE) 2016-11-10 — — US claimed
Send feedback